Form D/A — Advent Life Sciences Growth Fund LP
0002040586-25-000002 · filed Nov 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1), Investment Company Act Section 3(c)(7)
- Reported offering amount
- —
- Reported amount sold
- $9,800,250
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Advent Life Sciences Growth Fund LP
- CIK
- 2040586
- Entity
- Limited Partnership
- Jurisdiction
- UNITED KINGDOM
- Year incorporated
- 2023
- Address
- 27 FITZROY SQUARE
LONDON, United Kingdom W1T 6ES - Phone
- 44 020 7932 2120
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
- Advent Life Sciences LLP · Executive OfficerLondon, United Kingdom Find on LinkedIn ↗
-
Kaasim Mahmood · Executive OfficerLondon, United Kingdom Find on LinkedIn ↗
-
Shahzad Malik · Executive OfficerLondon, United Kingdom Find on LinkedIn ↗
-
Rajesh Parekh · Executive OfficerLondon, United Kingdom Find on LinkedIn ↗
-
Dominic Schmidt · Executive OfficerLondon, United Kingdom Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗